Skip to content

Diagnostic biomarker of research for dementia and mild cognitive impairment

Diagnostic biomarker of research for dementia and mild cognitive impairment

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021544
Enrollment
Unknown
Registered
2019-02-27
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia mild cognitive impairment

Interventions

Gold Standard:Clinical outcome: AD patients in accordance with the diagnostic criteria for probable AD from NIA - AA (2011)
VaD diagnosed by the National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en eurosciences(NINDS-AIREN) criteria.
Index test:P-tau?amyloid&#32
ß-protein

Sponsors

Weihai Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50-80 years, no limitation of sex; 2. Have the ability to complete tests for cognitive ability; 3. AD patients in accordance with the diagnostic criteria for probable AD from NIA - AA (2011); 4. VaD diagnosed by the National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en eurosciences(NINDS-AIREN) criteria; 5. Memory complaints reported by the patient, family, or physician, of at least a 6-month duration and preferably corroborated by an informant; Mild quantitative impairments in cognitive function were assessed by the Chinese version of the 30-point MoCA using age- and education-based norms (cutoff point was set at 1.5 SD below the mean age- and education-adjusted MoCA scores); Decreased daily living ability and social function, as measured by the daily living scale, score is below 18; Absence of dementia (according to DSM-IV criteria), psychiatric disorder, cerebral damage, or any active neuropsychiatric condition producing disability; Subjects conforming to five items above can be determined as MCI and included in our study.

Exclusion criteria

Exclusion criteria: 1. Other causes of cognitive decline: cerebrovascular disease, central nervous system infection, CJD, huntington's and Parkinson's disease, DLB, traumatic brain dementia, other physical and chemical factors (such as drugs, alcohol, CO), systemic disease (hepatic encephalopathy, pulmonary encephalopathy, etc.), intracranial occupation (a subdural hematoma, brain tumor), the endocrine system disease (thyroid disease, parathyroid disease), and vitamins deficiency or any other causes of dementia; 2. The history of nervous system diseases, including stroke, optic myelitis, Parkinson's disease, epilepsy, etc.); 3. Psychiatric patients, including schizophrenia or other mental illnesses, bipolar disorder, major depression or delirium; 4. Vision or hearing problems that lead to poor performance of cognitive test; 5. Embedded any metal implants (eg. cardiac pacemaker or intravascular stent); 6. The researchers believe that the subjects could not complete the study.

Design outcomes

Primary

MeasureTime frame
Cognition;Depression;

Countries

China

Contacts

Public ContactZhenguang Li

Weihai Municipal Hospital

drlizhenguang@163.com+86 18660388969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026